A Phase I Study Of Gleevec (Imatinib Mesylate) Administered Concomitantly With Cytosine Arabinoside (Ara-C) In Patients With Philadelphia Positive Chronic Myeloid Leukemia (Cml).Bj Druker,Hm Kantarjian,M Talpaz,R Paquette, Mj Mauro, M Rosamilia,U Zoellner, D Resta,R Capdeville,Cl SawyersBLOOD（2001）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
